From: Somatic mutation landscape in a cohort of meningiomas that have undergone grade progression
FEATURE | Number Patients | Number tumours | % NF2 mutant | % NF2 mutation not detected |
---|---|---|---|---|
LOSS 1p | 4 | 19 | 100% | 0% |
LOSS 10 (10, 10q) | 6 | 21 | 100% | 33% |
LOSS 22.q | 5 | 22 | 100% | 17% |
LOSS 9p | 3 | 9 | 75% | 17% |
LOSS 2p | 3 | 9 | 75% | 0% |
LOSS 3p or aberrant 3 | 3 | 12 | 75% | 0% |
LOSS 4p or aberrant 4 | 3 | 12 | 50% | 0% |
LOSS 14q | 2 | 10 | 50% | 0% |
LOSS 18q | 3 | 14 | 50% | 17% |
LOSS 5 (5, 5p, 5q) | 3 | 10 | 50% | 17% |
LOSS 6q or aberrant 6 | 4 | 14 | 50% | 33% |
LOSS 11 (11p, 11q, 11, focal) | 6 | 20 | 50% | 67% |
LOSS + GAIN 17q | 2 | 6 | 0% | 33% |